Tap These 5 Bargain Stocks With Alluring EV-to-EBITDA Ratio

The article advocates for the EV-to-EBITDA multiple as a more robust valuation tool than the traditional P/E ratio, particularly for assessing highly leveraged companies, acquisition targets, or firms with negative net earnings but positive EBITDA, due to its inclusion of debt and reduced susceptibility to accounting manipulation. While noting its industry-specific nature and recommending its use in conjunction with other metrics, the piece details a multi-factor screening approach that leverages EV-to-EBITDA, identifying specific companies like Astrana Health (ASTH), KT Corporation (KT), Upbound Group (UPBD), Noah Holdings (NOAH), and DXP Enterprises (DXPE) as attractive investment opportunities based on these criteria.

Analysis

The analysis advocates for the Enterprise Value-to-EBITDA (EV/EBITDA) multiple as a more robust valuation tool than the commonly used Price-to-Earnings (P/E) ratio, particularly for identifying undervalued companies. It posits that EV/EBITDA provides a more complete picture by incorporating a firm's total value, including debt, making it especially effective for evaluating highly leveraged firms or potential acquisition targets. The core of the report is a multi-factor screening model that identifies attractive stocks by combining low valuation multiples relative to industry peers—including EV/EBITDA, P/E, P/B, and P/S—with superior forward-looking fundamentals. Specifically, the screen selects for companies with estimated one-year EPS growth exceeding their industry median and a favorable Zacks Rank. This methodology has flagged five specific companies: Astrana Health (ASTH), KT Corporation (KT), Upbound Group (UPBD), Noah Holdings (NOAH), and DXP Enterprises (DXPE). These firms are highlighted not only for their favorable valuation profiles but also for strong growth outlooks and positive analyst sentiment, evidenced by significant expected 2025 earnings growth rates (ranging from 9.1% for UPBD to 280% for KT) and recent upward revisions to their consensus earnings estimates.

Key Decisions for Investors

• Investors should evaluate the five highlighted stocks—ASTH, KT, UPBD, NOAH, and DXPE—as they appear to be systematically undervalued, combining attractive valuation metrics with strong forward earnings growth and positive analyst estimate revisions.
• Given the emphasis on the EV-to-EBITDA multiple, these companies may also be considered potential M&A targets, offering an additional, event-driven catalyst for share price appreciation.
• Consider applying a similar multi-factor screening methodology, which prioritizes low valuation alongside high growth, to identify other potential opportunities, while remaining cognizant that valuation multiples like EV/EBITDA are most effective when compared within the same industry.
• Monitor the consensus earnings estimates and future earnings reports for these names closely, as the positive growth outlook is a critical component of the investment thesis presented.